Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Wallis

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Respiratory Medicine|July 26, 2005
Anti-tuberculosis treatment and infliximabRobert S Wallis
The European Respiratory Journal|November 2, 2016
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimineRobert S Wallis
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 1, 2005
Sutton's lawRobert S Wallis
The Journal of Infectious Diseases|June 3, 2009
Significance of early secreted antigenic target 6-specific T cell depletion after HIV-1 infectionRobert S Wallis
Current Opinion in HIV and AIDS|April 18, 2009
Corticosteroids and HIV infection: a review of experienceRobert S Wallis
Expert Review of Anti-Infective Therapy|April 4, 2007
Surrogate markers to assess new therapies for drug-resistant tuberculosisRobert S Wallis
The Journal of Investigative Dermatology. Symposium Proceedings|May 16, 2007
Reactivation of latent tuberculosis by TNF blockade: the role of interferon gammaRobert S Wallis
The Lancet. Infectious Diseases|October 17, 2008
Tumour necrosis factor antagonists: structure, function, and tuberculosis risksRobert S Wallis
Open Forum Infectious Diseases|March 4, 2015
Corticosteroid effects on sputum culture in pulmonary tuberculosis: a meta-regression analysisRobert S Wallis
American Journal of Respiratory and Critical Care Medicine|June 28, 2005
Can studies of the early bactericidal activity of rifapentine tell us how to prevent acquired rifamycin-resistant relapse?Robert S Wallis
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Respiratory Medicine|July 26, 2005
Anti-tuberculosis treatment and infliximabRobert S Wallis
The European Respiratory Journal|November 2, 2016
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimineRobert S Wallis
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 1, 2005
Sutton's lawRobert S Wallis
The Journal of Infectious Diseases|June 3, 2009
Significance of early secreted antigenic target 6-specific T cell depletion after HIV-1 infectionRobert S Wallis
Current Opinion in HIV and AIDS|April 18, 2009
Corticosteroids and HIV infection: a review of experienceRobert S Wallis
Expert Review of Anti-Infective Therapy|April 4, 2007
Surrogate markers to assess new therapies for drug-resistant tuberculosisRobert S Wallis
The Journal of Investigative Dermatology. Symposium Proceedings|May 16, 2007
Reactivation of latent tuberculosis by TNF blockade: the role of interferon gammaRobert S Wallis
The Lancet. Infectious Diseases|October 17, 2008
Tumour necrosis factor antagonists: structure, function, and tuberculosis risksRobert S Wallis
Open Forum Infectious Diseases|March 4, 2015
Corticosteroid effects on sputum culture in pulmonary tuberculosis: a meta-regression analysisRobert S Wallis
American Journal of Respiratory and Critical Care Medicine|June 28, 2005
Can studies of the early bactericidal activity of rifapentine tell us how to prevent acquired rifamycin-resistant relapse?Robert S Wallis
Pageof 11